MedPath

Effects of HIIT in Tolerance to Exercise of Individuals With HF and Coexisting COPD

Not Applicable
Suspended
Conditions
Chronic Obstructive Pulmonary Disease
Heart Failure
Interventions
Other: Continuous aerobic training
Other: High-intensity interval training
Registration Number
NCT04350541
Lead Sponsor
Universidade Federal de Pernambuco
Brief Summary

INTRODUCTION: The complexity of the pathophysiology of heterogeneous diseases such as heart failure and obstructive pulmonary disease causes a different approach to these diseases or with a view as much as a better understanding of the same situations, with which the clinical profile of patients who are associated with an association is. It is known that regular physical training promotes progressive improvements in exercise tolerance, in the pulmonary ventilation / perfusion ratio and in respiratory function by strengthening. OBJECTIVE: To compare the effects of high-intensity interval training and continuous aerobic exercise, with peripheral endothelial function, brain natriuretic peptide levels, maximum exercise tolerance, distribution of lung volumes and quality of life of patients with obstructive pulmonary disease associated with heart failure. METHODS: This is a clinical, controlled, randomized and blinded trial. Peripheral endothelial function, tolerance to maximum and submaximal exercise, distribution of lung volumes, quality of life, presence of symptoms of depression and perception of clinical change will be evaluated. EXPECTED RESULTS: Incorporate into the care of these patients, new effective therapeutic approaches, of low cost and with greater technical and scientific evidence.

Detailed Description

Not available

Recruitment & Eligibility

Status
SUSPENDED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Sedentary individuals with Heart Failure of all etiologies;
  • Diagnosed moderate and severe chronic obstructive pulmonary disease;
  • Clinical stability;
  • No change in the medication class within three months before the beginning of the research.
Exclusion Criteria
  • Unstable angina;
  • Myocardial infarction;
  • Previous cardiac surgery up to three months before the beginning of the study;
  • Hemodynamic instability;
  • Orthopedic and neurological diseases;
  • Psychological and/or mental impairment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Continuous trainingContinuous aerobic trainingThe continuous aerobic training will consist of 10 minutes of warm-up with intensity between 40 and 50% of VO2peak, 20 minutes of conditioning between 60 and 70% of VO2peak and 5 minutes of cooling down between 30 and 40% of VO2peak.
Interval trainingHigh-intensity interval trainingInterval training will consist of 10 minutes of warm-up between 40-50% of the peak oxygen consumption (VO2peak), followed by four to six repetitions of three-minute intervals between 80-90% of VO2peak and three minutes between 40-50% VO2peak and finally, five minutes of cooling down between 30-40% of VO2peak.
Primary Outcome Measures
NameTimeMethod
Peripheral endothelial function24 weeks

Evaluated by the peripheral arterial tonometry using the EndoPat 2000 device

Exercise tolerance24 weeks

Evaluated by the cardiopulmonary exercise test by measuring the maximum oxygen consumption.

Secondary Outcome Measures
NameTimeMethod
Perception of clinical change24 weeks

Evaluated by the Patient Global Impression of Change Scale which is a one-dimensional measure in which individuals can rate their associated improvement on a 7-item scale ranging from "1 = no changes" to "7 = much better".

Quality of life assessment: Short Form-36 questionnaire24 weeks

Evaluated by the Short Form-36 questionnaire

Distance covered in the six-minute walk test24 weeks

Evaluated by the six-minute walk test

Trial Locations

Locations (1)

Federal University of Pernambuco

🇧🇷

Recife, Pernambuco, Brazil

© Copyright 2025. All Rights Reserved by MedPath